1
Beta-thalassemia and Microparticles
Condition(s): Thalassemia Major (TM); Thalassemia Intermedia (TI); Microparticles (MP)Originating From Platelets, Endothelial Cells and Monocytes Last Updated: January 26, 2011Recruiting
83 Clinical Trials for: “Beta-Thalassemia”, Page 1 of 5
Hide Studies Not Seeking New Volunteers
2
Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia
Condition(s): Beta-Thalassemia Last Updated: June 19, 2008Completed
3
Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment
Condition(s): Beta-thalassemia; Iron Overload Last Updated: April 25, 2012Completed
4
A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
Condition(s): Beta-Thalassemia; Hemosiderosis Last Updated: May 5, 2010Completed
5
Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)
Condition(s): Beta Thalassemia; Hemoglobinopathy Last Updated: March 3, 2008Completed
6
Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major
Condition(s): Beta-Thalassemia Last Updated: September 12, 2012Recruiting
7
Efficacy Study of the Use of Sequential DFP-DFO Versus DFP
Condition(s): Beta-Thalassemia; Thalassemia Major Last Updated: August 12, 2008Completed
8
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)
Condition(s): Beta-thalassemia Major; Hemosiderosis; Iron Overload; Rare Anemia Last Updated: August 28, 2011Completed
9
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload
Condition(s): Myelodysplastic Syndromes; Beta-Thalassemia Last Updated: September 8, 2011Completed
10
Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major
Condition(s): Beta-Thalassemia Last Updated: December 18, 2012Completed
11
A Study Evaluating the Safety and Efficacy of the LentiGlobin® BB305 Drug Product in Beta-Thalassemia Major Subjects
Condition(s): Beta-thalassemia Major Last Updated: May 13, 2013Not yet recruiting
12
Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions
Condition(s): Beta-Thalassemia Last Updated: April 18, 2012Completed
13
Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major
Condition(s): Beta-Thalassemia Last Updated: June 23, 2005Active, not recruiting
14
Study of ACE-536 to Evaluate the Effects of ACE-536 in Patients With Beta-thalassemia Intermedia
Condition(s): Beta-thalassemia. Last Updated: March 14, 2013Recruiting
15
Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI
Condition(s): Osteoporosis; Thalassemia Major; Thalassemia Intermedia Last Updated: June 8, 2010Completed
16
Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia
Condition(s): Beta Thalassemia Last Updated: May 18, 2011Completed
17
Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
Condition(s): Beta-thalassemia; Myelodysplastic Syndromes; Fanconi Syndrome; Anemia, Diamond-Blackfan; Anemia, Aplastic Last Updated: March 2, 2011Completed
18
Trial of HQK-1001 in Beta Thalassemia Intermedia in Lebanon
Condition(s): Beta Thalassemia Intermedia Last Updated: March 13, 2013Completed
19
Genetic Factors Affecting the Severity of Beta Thalassemia
Condition(s): Beta Thalassemia Last Updated: June 22, 2011Recruiting
20
Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients
Condition(s): Beta-Thalassemia; Bone Marrow Transplantation Last Updated: July 25, 2011Active, not recruiting
